Investment Summary

Vitamica is seeking to exploit a novel approach for determining the susceptibility of bacteria to antibiotics. Resistance of bacteria to antibiotics is an increasing problem across the world, resulting in poorer healthcare outcomes, higher costs and a reduction in the number of effective drugs.